Dermatology Research

The Alfred dermatology research team are leaders in their fields, with decades of Australian and international experience.

Focus areas

Our researchers are focussed on new treatments for common skin conditions such as eczema and psoriasis as well as advancements in the treatment of more rare conditions such as vitiligo, hidradenitis suppurativa, bullous pemphigoid and urticaria.

Achievements

Professor Johannes Kern (Alfred Dermatology/Monash Central Clinical School) together with Dr Asolina Braun (Monash Biomedicine Discovery Institute) received a LEO Foundation grant for their project to identify antigen triggers of psoriasis.

Alfred dermatology clinical trials participate in the Medical Research Future Funds (MRFF) funded SiroSkin trial on prevention of skin squamous cell carcinoma in solid organ transplant recipients.

Professor Johannes Kern is the global coordinating investigator of the CSL324_1002 phase IB, first in-patient trial, for patients with palmoplantar pustulosis and hidradenitis suppurativa.

Our Team

Prof Johannes S Kern

Johannes is a conjoint Professor and Director of Dermatology, Monash University School of Translational Medicine and Alfred Health.

Find out more
A/Prof Sue Yen Michelle Goh

A/Prof Michelle Goh is a Fellow of the Australasian College of Dermatologists (FACD).

Find out more
Dr Charlotte Krones

Charlotte, our Clinic and Trials Fellow, is a strong patient advocate and has a strong emphasis on patient-centred care.

Find out more
Dr Priska McDonald
Dr Thuvarahan Jegathees
Find out more

Are you interested in our dermatology clinical trials?

The unit is focused on new treatments for common conditions such as eczema and psoriasis as well as advancements in the treatment of more rare conditions.

Read more

Publications

Effect of methotrexate on melanoma risk in older adults: Secondary analysis of a randomised controlled trial

Yan MK, Wolfe R, Orchard SG, Ernst ME, Mar VJ

(2022), Australas J Dermatol, 63(1), 114-5

DOI: 10.1111/ajd.13727

Improving Skin cancer Management with ARTificial Intelligence (SMARTI): protocol for a preintervention/postintervention trial of an artificial intelligence system used as a diagnostic aid for skin cancer management in a specialist dermatology setting

Felmingham C, MacNamara S, Cranwell W, Williams N, Wada M, Adler NR, Ge Z, Sharfe A, Bowling A, Haskett M, Wolfe R, Mar V

(2022), BMJ Open, 12(1), e050203

DOI: 10.1136/bmjopen-2021-050203

Sensitivity of two Australian melanoma risk tools to identify high-risk individuals among people presenting with their first primary melanoma

Tan K, Lo SN, Cust AE, Wolfe R, Mar V

(2022), Australas J Dermatol, 63(3), 352-8

DOI: 10.1111/ajd.13841

View all publications for Dermatology Research
News & articles
from Alfred Health
Read latest news